Hyperactivity of the mTORC1 pathway has been demonstrated in: experimental animal models of mTORopathies; in vitro functional assessments of epilepsy-causative mTOR pathway genetic variants; and resected brain tissue from patients with FCD and HME.13 This evidence concerns the gene MTOR and epilepsy.